![Boceprevir, Experimental Drug for Chronic Hepatitis C Infection by Schering-Plough - Clinical Trials Arena Boceprevir, Experimental Drug for Chronic Hepatitis C Infection by Schering-Plough - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1-boceprevir.jpg)
Boceprevir, Experimental Drug for Chronic Hepatitis C Infection by Schering-Plough - Clinical Trials Arena
![Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial - The Lancet Infectious Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial - The Lancet Infectious](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2012777122/2034884324/gr3.jpg)
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial - The Lancet Infectious
Treatment of Hepatitis C with Pegylated Interferon and Ribavirin with or without Boceprevir or Telaprevir
Drug Monograph Brand Name: Victrelis Generic Name: Boceprevir Manufacturer : MERCK & CO., INC. Drug Class : Protease Inhibit
![Boceprevir, Experimental Drug for Chronic Hepatitis C Infection by Schering-Plough - Clinical Trials Arena Boceprevir, Experimental Drug for Chronic Hepatitis C Infection by Schering-Plough - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/2-hcv-symptoms.jpg)